Pages that link to "Q34086152"
Jump to navigation
Jump to search
The following pages link to The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance (Q34086152):
Displaying 44 items.
- Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms (Q27692033) (← links)
- Putting tumours in context (Q28207789) (← links)
- Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma (Q28248137) (← links)
- Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors (Q28553729) (← links)
- The breast cancer beta 4 integrin and endothelial human CLCA2 mediate lung metastasis (Q33943941) (← links)
- Multiple myeloma: evolving genetic events and host interactions (Q34624999) (← links)
- Role of inherited defects decreasing Fas function in autoimmunity. (Q35107838) (← links)
- Global Gene Expression Profiling in the Study of Multiple Myeloma (Q35121615) (← links)
- Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling (Q35170930) (← links)
- Bortezomib (PS-341): A Novel, First-in-Class Proteasome Inhibitor for the Treatment of Multiple Myeloma and Other Cancers (Q35569454) (← links)
- A review of the proteasome inhibitor bortezomib in multiple myeloma (Q35784057) (← links)
- MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model (Q35791530) (← links)
- Extracellular matrix in bone marrow can mediate drug resistance in myeloma (Q36194659) (← links)
- Correlation between the tumoral expression of beta3-integrin and outcome in cervical cancer patients who had undergone radiotherapy (Q36615716) (← links)
- A physical sciences network characterization of non-tumorigenic and metastatic cells (Q36795613) (← links)
- Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3. (Q36962815) (← links)
- Liposomes targeting tumour stromal cells. (Q37799613) (← links)
- Environmental-mediated drug resistance: a target for multiple myeloma therapy (Q37810085) (← links)
- Computational challenges of tumor spheroid modeling (Q37903301) (← links)
- Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation (Q37973062) (← links)
- Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death (Q38040787) (← links)
- Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review (Q38109551) (← links)
- Cell adhesion down-regulates the expression of vacuolar protein sorting 4B (VPS4B) and contributes to drug resistance in multiple myeloma cells (Q38895636) (← links)
- Evolutionary scalpels for dissecting tumor ecosystems (Q39030938) (← links)
- Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells (Q39095903) (← links)
- An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy (Q39180729) (← links)
- Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion (Q39562168) (← links)
- Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4 (Q39761913) (← links)
- Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation (Q39893169) (← links)
- HSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma (Q39978610) (← links)
- IL-6 regulates CD44 cell surface expression on human myeloma cells (Q40579834) (← links)
- Hyaluronan, a major non‐protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma (Q40655653) (← links)
- Prolactin influences proliferation and apoptosis of a human IgE secreting myeloma cell line, U266. (Q40728795) (← links)
- Circulating endothelial cells and their progenitors in acute myeloid leukemia. (Q41153604) (← links)
- Stimulation of Toll-like receptor-1/2 combined with Velcade increases cytotoxicity to human multiple myeloma cells (Q41876189) (← links)
- Cancer stem cell and stromal microenvironment (Q42540118) (← links)
- Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms (Q44452179) (← links)
- The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells. (Q44541080) (← links)
- Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibition. (Q46830755) (← links)
- Reduced risk of apoptosis: mechanisms of stress responses (Q51347935) (← links)
- Apoptotic cell death in mammary adenocarcinoma cells is prevented by soluble factors present in the target organ of metastasis (Q77397517) (← links)
- Involvement of TGF-beta(s)/T(beta)Rs system in tumor progression of murine mammary adenocarcinomas (Q79077062) (← links)
- A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth (Q87678165) (← links)
- Exosome mediated multidrug resistance in cancer (Q90573157) (← links)